About Mitral Regurgitation
Mitral regurgitation (MR) is a condition in which the mitral valve becomes ineffective, allowing flow from the left ventricle (LV) into the left atrium during ventricular systole. MR can be caused by either LV dilation or infarction. Progression of heart failure, arrhythmias, and endocarditis are all possible complications. Patients with mild, asymptomatic MR can be monitored, but patients with progressive or symptomatic MR need mitral valve repair or replacement. Minimally or non-invasive therapies, as well as many other techniques, are currently in development for patients who are at high risk or inoperable. This technological advancement provides cardiac surgeons and interventional cardiologists with new ways to meet the needs of their patients. The growing prevalence of heart disease expands the patient pool, increasing the demand for better treatment and novel products.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 9.1% |
The demand for Mitral Regurgitation is increasing. Businesses in this sector face global competition from market leaders who control a large share of the market. Companies are differentiating their products from competition by employing environmentally friendly materials and manufacturing techniques. The Leading Players are engaging in strategic global expansion to maintain their Market Position. Players are expected to focus on the creation of new compounds, which would likely drive the worldwide market forward over the forecast period. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Mitral Regurgitation market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Abbott Laboratories (United States), Edwards Lifesciences (United States), Cedars-Sinai Medical Center (United States), Stanford Health Care (United States), Beaumont Health (United States), Neovasc Inc. (Canada), LivaNova PLC (United Kingdom), Boston Scientific (United States), Geisinger (United States) and Venus MedTech HangZhou Inc (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Cardiac Dimensions (United States), Affluent Medical (France) and Coramaze Technologies (Germany).
Segmentation Overview
AMA Research has segmented the market of Global Mitral Regurgitation market by Type (Chronic and Acute) and Region.
On the basis of geography, the market of Mitral Regurgitation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. Mitral Valve Repair will boost the Mitral Regurgitation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-User, the sub-segment i.e. Hospitals will boost the Mitral Regurgitation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Diagnosis, the sub-segment i.e. Physical Examination will boost the Mitral Regurgitation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Advent of Novel Mitral Valves and Growing Adoption of Non-Invasive Transcatheter Therapies
Market Growth Drivers:
Rising Number of Heart Diseases Heart and Increase in Mitral Valve Disorders
Challenges:
High Risk of Side Effects of Treatment and Availability of Low-Cost Counterfeit Products
Restraints:
Stringent Regulations by the Governing Bodies and High Cost of Mitral Regurgitation Surgery
Opportunities:
Rising Technological Advancements
Market Leaders and their expansionary development strategies
In October 2020 Medtronic announced a partnership with The Foundry to develop Mitral Valve Repair Technology. The collaboration combines Medtronic’s structural heart and intellectual property with The Foundry's innovation in transcatheter mitral valve repair and replacement.
In September 2023, HighLife launches a new Large Annulus Valve in ongoing clinical studies for patients suffering from Mitral Regurgitation.
Key Target Audience
Potential Investors, Market Research & Consultancy Firm, Government & Regulatory Bodies and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.